Jay Kunkel Sells 8,121 Shares of Varex Imaging (NASDAQ:VREX) Stock

Varex Imaging (NASDAQ:VREX) Director Jay Kunkel sold 8,121 shares of the firm’s stock in a transaction on Monday, September 14th. The stock was sold at an average price of $18.48, for a total value of $150,076.08. Following the transaction, the director owned 15,329 shares of the company’s stock, valued at approximately $283,279.92. This represents a 34.63% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

Varex Imaging Trading Up 0.1%

Shares of VREX stock traded up $0.01 on Tuesday, hitting $18.47. The stock had a trading volume of 548,724 shares, compared to its average volume of 526,859. The company has a debt-to-equity ratio of 0.64, a current ratio of 3.38 and a quick ratio of 1.53. The firm has a market capitalization of $777.59 million, a P/E ratio of 35.52 and a beta of 0.96. Varex Imaging has a 1 year low of $9.09 and a 1 year high of $18.63. The company’s 50 day moving average price is $14.95 and its 200-day moving average price is $12.37.

Varex Imaging (NASDAQ:VREX) last announced its earnings results on Monday, August 10th. The company reported $0.31 EPS for the quarter, beating analysts’ consensus estimates of $0.21 by $0.10. Varex Imaging had a return on equity of 9.19% and a net margin of 2.55%.The company had revenue of $210.50 million during the quarter, compared to analysts’ expectations of $215.50 million. Analysts anticipate that Varex Imaging will post 1.04 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several research analysts have recently commented on VREX shares. Zacks Research lowered shares of Varex Imaging from a “strong-buy” rating to a “hold” rating in a research note on Monday, July 27th. Oppenheimer downgraded shares of Varex Imaging from an “outperform” rating to a “market perform” rating in a research note on Monday, August 10th. CJS Securities lowered shares of Varex Imaging from an “outperform” rating to a “market perform” rating in a report on Monday, August 17th. Wall Street Zen raised shares of Varex Imaging from a “hold” rating to a “buy” rating in a research report on Saturday, July 4th. Finally, Weiss Ratings raised shares of Varex Imaging from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Wednesday, August 26th. Seven investment analysts have rated the stock with a Hold rating, According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $16.88.

Institutional Investors Weigh In On Varex Imaging

Large investors have recently bought and sold shares of the stock. Pzena Investment Management LLC purchased a new position in shares of Varex Imaging in the 2nd quarter valued at about $45,312,000. BlackRock Inc. acquired a new position in shares of Varex Imaging during the second quarter worth about $40,624,000. Cooke & Bieler LP grew its position in shares of Varex Imaging by 2.2% during the fourth quarter. Cooke & Bieler LP now owns 1,632,525 shares of the company’s stock worth $19,019,000 after buying an additional 35,042 shares in the last quarter. Rice Hall James & Associates LLC purchased a new stake in shares of Varex Imaging during the second quarter worth approximately $15,080,000. Finally, LSV Asset Management increased its stake in shares of Varex Imaging by 210.7% during the fourth quarter. LSV Asset Management now owns 1,244,329 shares of the company’s stock worth $14,496,000 after buying an additional 843,805 shares during the period.

Varex Imaging Company Profile

Varex Imaging Corporation (NASDAQ: VREX) develops and manufactures X-ray imaging components used by medical, industrial and security equipment manufacturers. Its products are incorporated into systems that support diagnostic imaging, radiation therapy, inspection and threat detection.

The company’s portfolio includes X-ray tubes, digital image detectors, high-voltage generators, image-processing software and other imaging subsystems. These products are used in applications such as computed tomography, radiography, fluoroscopy, mammography, dental and veterinary imaging, as well as industrial non-destructive testing and security screening.

Varex Imaging was established as an independent public company in 2017 through a spin-off from Varian Medical Systems.